Consistent with its tumor suppressive function, TIF1γ expression is significantly reduced in most tumors, including lung cancer, pancreatic cancer, liver cancer, and glioblastoma, while it is increased in other tumors such as colorectal cancer and breast cancer [10,12]. This evidence concerns the gene TRIM33 and pancreatic neoplasm.